These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6138376

  • 21. Electropharmacology of flestolol for supraventricular tachycardia without associated structural heart disease.
    Swerdlow C, Peterson J, Liem LB, Blake K, Franz MR, Laddu A.
    Am J Cardiol; 1987 Nov 01; 60(13):1055-60. PubMed ID: 2890290
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of almokalant, a class III antiarrhythmic agent, on supraventricular, reentrant tachycardias. Almokalant Paroxysmal Supraventricular Tachycardia Study Group.
    Darpö B, Edvardsson N.
    Cardiovasc Drugs Ther; 1997 Jul 01; 11(3):499-508. PubMed ID: 9310280
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F.
    G Ital Cardiol; 1987 May 01; 17(5):444-9. PubMed ID: 3115857
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intravenous dantrolene does not exhibit calcium channel blocking effects on the cardiac conduction system in humans.
    Kentsch M, Roewer N, Kunze KP, Kuck KH.
    Anesthesiology; 1991 Oct 01; 75(4):583-7. PubMed ID: 1928768
    [Abstract] [Full Text] [Related]

  • 36. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM, Friday KJ, Fitzgerald DM, Yeung-Lai-Wah JA, Lazzara R.
    Am J Cardiol; 1988 Dec 20; 62(19):8L-19L. PubMed ID: 3059792
    [Abstract] [Full Text] [Related]

  • 37. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R.
    Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739
    [Abstract] [Full Text] [Related]

  • 38. [Slow and fast AV nodal pathways in tachycardia complicating Wolff-Parkinson-White syndrome: report of a case].
    Vitale P, Santangelo L, Vitale N, Nave C, Civitillo UF, Curcio N, Iacono A.
    Cardiologia; 1992 Nov 01; 37(11):775-80. PubMed ID: 1298547
    [Abstract] [Full Text] [Related]

  • 39. Atypical forms of supraventricular tachycardia due to atrioventricular node reentry in children after radiofrequency modification of slow pathway conduction.
    Silka MJ, Kron J, Park JK, Halperin BD, McAnulty JH.
    J Am Coll Cardiol; 1994 May 01; 23(6):1363-9. PubMed ID: 8176094
    [Abstract] [Full Text] [Related]

  • 40. Beta-adrenoceptor blockade: electrophysiology and antiarrhythmic mechanisms.
    Sung RJ, Tai DY, Svinarich JT.
    Am Heart J; 1984 Oct 01; 108(4 Pt 2):1115-20. PubMed ID: 6148871
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.